NCT03413982Recruiting
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Source: ClinicalTrials.gov · Last updated 10 Mar 2026
Brief summary (registry, in English)
The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 10 Jan 2018
- Start date
- 2 Nov 2017
- Primary completion date
- 1 Jan 2035
- Lead sponsor
- University of Kansas Medical Center
- Diseases
- Bladder cancer
- NCT number
- NCT03413982
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 2 Nov 2017 to the primary completion date, 1 Jan 2035
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients who do not have presumed bladder cancer will not be eligible
Who the study is looking for
- Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
- Patients can participate in any additional research studies during the patients' participation within this protocol.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Kansas Medical Center Coordinator of this site? Confirm its status | Kansas City | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.